Review assesses CCT6A as a disease biomarker and therapeutic target
A 2026 review presents CCT6A as a candidate diagnostic and prognostic biomarker in cancer while highlighting context-dependent mechanisms, absent subunit-specific ...
Tag: CCT6A
POPULAR NEWS
-
Retrospective machine learning models predict amputation risk in diabetic arterial disease
-
Genome-wide analysis links tumor deletion patterns to alternative DNA repair
-
Review assesses CCT6A as a disease biomarker and therapeutic target
-
Phage Therapy Against Multidrug-Resistant Serratia Remains an Investigational Strategy